Jeremy Yuen-Chun Teoh,1,2 Ashish M. Kamat,3 Peter C. Black,4 Petros Grivas,5,6 Shahrokh F. Shariat7,8,9,10,11,12 and Marek Babjuk7,12
- Jeremy Yuen-Chun Teoh S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China
- European Association of Urology-Young Academic Urologists (EAU-YAU) Urothelial Cancer Working Group, Amsterdam, Netherlands
- The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada
- Division of Oncology, Department of Medicine, University of Washington, Washington, USA
- Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA, USA
- Department of Urology, Medical University of Vienna, Vienna, Austria
- Department of Urology, Weill Cornell Medical College, New York, NY, USA
- Department of Urology, University of Texas Southwestern, Dallas, TX, USA
- Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
- Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan
- Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic
Source: Teoh, J.YC., Kamat, A.M., Black, P.C. et al. Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective. Nat Rev Urol (2022). https://doi.org/10.1038/s41585-022-00578-1